Tagged ‘Dabigatran’

Journal Review

Idarucizumab for Dabigatran Reversal II

Filed Under: Tags: , , , March 29th, 2018 Leave a Comment

Dabigatran is an oral direct thrombin inhibitor, touted as non-inferior to Warfarin (though there is some debate about its safety (Yao, Abraham et al. 2016, Hernandez, Baik et al. 2018).
Read More

Journal Review

Idarucizumab for Reversal of Dabigatran

Filed Under: Tags: , , January 21st, 2016 Leave a Comment

Dabigatran Site of Action (www.medscape.com)

The burdens associated with the use of traditional anticoagulants such as subcutaneous heparins and oral vitamin K antagonists (VKAs) have spurred the popularity of non-vitamin K oral anticoagulants (NOACs) for stroke prevention in patients with nonvalvular atrial fibrillation and for the prevention and treatment of venous thromboembolism.
Read More